Rock Creek Pharmaceuticals's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Rock Creek Pharmaceuticals in the second quarter 2016?
Due to the lack of equity, it was not possible to calculate Rock Creek Pharmaceuticals, Inc.'s return on equity (ROE) in its second quarter 2016

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2016) II. Quarter	(Mar 31 2016) I. Quarter	(Dec 31 2015) IV. Quarter	(Sep 30 2015) III. Quarter	(Jun 30 2015) II. Quarter
Y / Y Equity Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-11	-9	-7	-13	-20
Return On Equity (TTM)	-	-	-	-	-
RCPI's Total Ranking	#	#	#	#	#
Equity (TTM) in Millions	-13	-12	-11	-9	-7
Seq. Equity Change	-	-	-	-	-
Seq. Net Income Change	-	-	-	-	-

Back to RCPI Management Effectiveness >> RCPI's 5 Years Annual ROE >> Compare RCPI ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Equity Statistics
High	Average	Low
0 %	0 %	0 %

RCPI Annual Return On Equity	(Dec 31 2015) 2015	(Dec 31 2014) 2014	(Dec 31 2011) 2011
Total Equity in Millions	-11	-11	9	0	0
Y / Y Equity Change	-	-	-	-	-
Net Income in Millions	-7	-39	-38	0	0
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-	-	-404.51 %	-	-

Back to RCPI Management Effectiveness >> RCPI's 5 Years Annual ROE >> Compare RCPI ROE to its Competitors

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
RCPI's' Return on Equity at Yahoo Finance
RCPI's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for RCPI's Competitors
Subscribers only: Roe for Rock Creek Pharmaceuticals's Suppliers
Subscribers only: Return On Equity for RCPI's Customers

Companies with similar Return On Equity at Jun 30 2016, within Healthcare Sector	ROE
Oncternal Therapeutics Inc	229.28 %
Fonar Corporation	181.73 %
Moderna Inc	179.14 %
Tuhura Biosciences Inc	152.63 %
Phibro Animal Health Corporation	150.13 %
Abbvie Inc	119.85 %
Gilead Sciences Inc	97.28 %
Lifevantage Corp	87.90 %
Odonate Therapeutics Inc	87.64 %
First Choice Healthcare Solutions Inc	82.76 %
Adaptive Biotechnologies Corporation	78.72 %
Enzo Biochem Inc	74.18 %
Viskase Holdings inc	70.60 %
Ligand Pharmaceuticals Incorporated	70.23 %
Five Prime Therapeutics Inc	69.60 %
Aclaris Therapeutics Inc	65.00 %
Mettler toledo International Inc	64.93 %
Adm Tronics Unlimited Inc	61.96 %
United Therapeutics Corporation	61.50 %
Titan Pharmaceuticals Inc	61.24 %
Baxter International Inc	56.05 %
Star Equity Holdings Inc	54.27 %
Zoetis Inc	52.05 %
Jrsis Health Care Corp	51.10 %
Cba Florida Inc	45.99 %
Syneos Health Inc	43.23 %
Achari Ventures Holdings Corp I	42.57 %
3m Company	41.91 %
Incyte Corporation	37.76 %
Biogen Inc	37.11 %

Date modified: 2026-09-08T15:08:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.